Praram 9 Hospital Public Company Limited

SET:PR9-R Stock Report

Market Cap: ฿20.6b

Praram 9 Hospital Past Earnings Performance

Past criteria checks 5/6

Praram 9 Hospital has been growing earnings at an average annual rate of 27.2%, while the Healthcare industry saw earnings growing at 11.8% annually. Revenues have been growing at an average rate of 12.7% per year. Praram 9 Hospital's return on equity is 13%, and it has net margins of 15.1%.

Key information

27.2%

Earnings growth rate

27.1%

EPS growth rate

Healthcare Industry Growth23.6%
Revenue growth rate12.7%
Return on equity13.0%
Net Margin15.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Praram 9 Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SET:PR9-R Revenue, expenses and earnings (THB Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,6056948060
30 Jun 244,4476267920
31 Mar 244,3656087730
31 Dec 234,2535587740
30 Sep 234,1785097830
30 Jun 234,1755167800
31 Mar 234,1395197590
31 Dec 224,1505687350
30 Sep 223,9805456780
30 Jun 223,6654816180
31 Mar 223,3273685840
31 Dec 213,0262495570
30 Sep 212,8262145280
30 Jun 212,7672045260
31 Mar 212,6462035130
31 Dec 202,6332025180
30 Sep 202,6371955400
30 Jun 202,6862115470
31 Mar 202,8412365770
31 Dec 192,8762845700
30 Sep 192,8421786650
30 Jun 192,8091766520
31 Mar 192,7741916380
31 Dec 182,7271576540
30 Sep 182,6892745250
30 Jun 182,6202685160
31 Mar 182,5432664920
31 Dec 172,4552624560
31 Dec 162,2592674040
31 Dec 151,9821943740
31 Dec 141,7941623150

Quality Earnings: PR9-R has high quality earnings.

Growing Profit Margin: PR9-R's current net profit margins (15.1%) are higher than last year (12.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PR9-R's earnings have grown significantly by 27.2% per year over the past 5 years.

Accelerating Growth: PR9-R's earnings growth over the past year (36.5%) exceeds its 5-year average (27.2% per year).

Earnings vs Industry: PR9-R earnings growth over the past year (36.5%) exceeded the Healthcare industry 11.1%.


Return on Equity

High ROE: PR9-R's Return on Equity (13%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies